Back to Latest News

• 5/15/2012 DNA Biomarker Discovery Focuses on DNA Methylation
• 4/17/2012 Proton Therapy Update: No Evidence That Benefits Justify Cost
• 4/17/2012 HIFU Technology Progresses, More Clinical Research Is Needed
• 4/9/2012 Prostate and Breast Cancer Vaccine Progressing
• 4/5/2012 PCF Researcher Dr. Carl June Presents Results on "Performance Enhanced" T-Cell Therapy in Leukemia
• 4/5/2012 Dr. Karen Knudsen Identifies "Next Generation" Gene Targets for Prostate Cancer
• 4/5/2012 PCF Scientific Advisory Board Member Martin G. Pomper Speaks on Molecular Imagining and Theranostics
• 4/4/2012 Dr. Charles Sawyers Discusses the Coming of Age in Pathway-Targeted Therapeutics, MDV3011
• 4/4/2012 Data Presented by Dr. Sarah Nechuta on the Role of Cruciferous Vegetables and Sulphorophane in Broccoli
• 4/4/2012 Correlation Between Excess Body Weight and Prostate Cancer Identified by Dr. Vincent Freeman
• 4/4/2012 PCF-Supported Researcher Dr. Chuck Ryan Focuses on New Prostate Cancer Drugs
• 4/3/2012 PCF-Funded Investigator Presents on Investigational Drug Galeterone
• 4/3/2012 Dr. Gulley, PCF-Supported Scientist, Discusses Differences in Targeted and Immune Therapies
• 4/3/2012 PCF-Funded Young Investigator Presents Research on Imaging Androgen Receptor Signaling
• 4/3/2012 Bringing Next-Generation Sequencing to the Cancer Clinic for Precision Medicine
• 4/2/2012 PCF-Funded Researcher Presents Data on Chromatin States Found In Stem Cells
• 4/2/2012 PCF Partner Institutions Honored at AACR Opening Ceremony
• 4/2/2012 PCF Award Recipient Steven Balk Chairs Session on Advances in Androgen Receptor Discovery
• 4/1/2012 PCF-Funded Scientists Say Diabetes Medication Shows Promise Against Cancers, Including Prostate
• 4/1/2012 Robotic High-Throughput Screen Featured at AACR
• 4/1/2012 PCF Support Facilitates AACR Recognition Awards
• 3/23/2012 Dr. Ballentine Carter Elected Trustee of the American Board of Urology
• 3/23/2012 Dr. Charles Sawyers Elected AACR President
• 3/22/2012 Scientists Identify New Mechanism of Prostate Cancer Cell Metabolism
• 3/14/2012 Dr. Patrick Walsh, Renowned Prostate Cancer Researcher, Receives the Amory Prize
• 3/12/2012 PCF Initiates China Research Program
• 3/9/2012 Novel Therapy Zytiga Approved by FDA for Metastatic Prostate Cancer
• 3/9/2012 PCF Announces Winners of Young Investigator Award in China
• 3/8/2012 China on Front Lines of Fight Against Prostate Cancer
• 2/27/2012 Cancer Discovery Shows Promise of New Drugs
• 2/24/2012 Active Biotech and Ipsen report for the first time Tasquinimod (TASQ) phase II long term safety data
• 2/21/2012 A Driver of Prostate Cancer Progression Identified by Two PCF-Funded Researchers
• 2/13/2012 Nerve Sparing Study Plays Important Role in Sexual Function
• 2/10/2012 Mentorship and Data Exchange Expand Prostate Cancer Research
• 2/9/2012 Heart Disease May Be a Risk Factor for Prostate Cancer
• 2/9/2012 Brachytherapy Can Be Successful for High-Risk Prostate Cases, Too
• 2/8/2012 ProstaCaid™ Inhibits Tumor Growth in a Xenograft Model of Human Prostate Cancer [JOURNAL]
• 2/8/2012 Third Peer-Reviewed Study Proves Botanical Formula Fights Prostate Cancer Without Toxicity
• 2/7/2012 Urine Test Could Supplement Prostate Cancer Biopsy  | PCF funding continues to advance early diagnostics
• 2/7/2012 Fast Track Treatment Continues to Make Progress
• 2/2/2011 OGX-427 Used with Prednisone Shows Promising Results for Prostate Cancer Patients
• 2/2/2012 Promising New Therapeutic Targets Bone and Disperses Radiation | Alpharadin may decreases bone metastases and reduce death
• 2/1/2012 Researchers’ Work in Prostate Cancer and Exercise Advances | June Chan focuses on early-stage disease
• 1/27/2012 PCF Lays the Foundation for Roswell Park Vaccine Trial
• 1/11/2012 A Model For Life Sciences Research Funding
• 1/5/2012 Energy and Advocacy Preserve Crucial PCa Research Funds
• 11/3/2011 PCF Funding Leads to MDV3100 Clinical Successes | All trial participants receive drug, not placebo.
• 11/1/2011 Memorial Sloan-Kettering Researchers Discover Prostate Cancer Disease Pathways Regulate Each Other | Researchers discover a specific combination of inhibitors which cause tumor recession in mouse models.
• 11/1/2011 AgonOx Partners with MedImmune for Development of OX40 Agonists in Cancer Therapy | PCF-funded researchers partner with AgonOx Partners and MedImmune to develop tumor-specific agonist.
• 9/27/2011 U.S. Scientists Map Genome of Advanced Prostate Cancer | Researchers discover genetic 'hypermutations' that help tumors resist common therapies
• 9/19/2011 FDA Expands Approval for Denosumab
• 9/7/2011 Abiraterone (Zytiga) Approved in European Union
• 8/23/2011 FDA to Decide by April 26 on New Xgeva Application| Prevention of metastases represents promising new use for Xgeva
• 8/23/2011 FDA Grants Fast Track Designation to Radium-223 Chloride for the Treatment of Castration-Resistant Prostate Cancer That Has Spread to the Bone| Decision may make new treatment available for patients faster
• 8/22/2011 5-Gene Signature Identifies Lethal Varieties of Prostate Cancer and May Better Direct Patients to Appropriate Levels of Treatment | Discovery enabled by collaborative effort of scientists at more than a dozen institutes in U.S. and Sweden
• 7/29/2011 UT Southwestern PCF Young Investigator Identifies New Pathway Explaining Resistance to Prostate Cancer Treatment | Discovery Opens Door to New Target for Drug Development
• 7/28/2011 Abiraterone (Zytiga) Approved in Canada
• 7/27/2011 Intermittent Androgen Deprivation | Changing the standard of care for men with recurrent prostate cancer
• 7/25/2011 Final European Approval of Abiraterone (Zytiga) Expected Within Weeks | Approval will open new treatment option for more than 70,000 patients each year in the EU 
• 7/6/2011 Stearns' Amendment to Increase Prostate Cancer Research under Department of Defense Gets Bipartisan Approval | $16 Million Increase in Prostate Cancer Research Adopted by Voice Vote
• 6/27/2011 Duke Team Finds New Clues to How Cancer Spreads | PCF-funded investigator lead author of the study
• 5/23/2011 Half of Prostate Cancers Could Potentially Benefit From New Type of Cancer Drugs | Work was a team effort led by PCF-funded investigator Dr. Arul Chinnaiyan
• 4/6/2011 KRAS Gene Fusion in Prostate Cancer

Back to Latest News